A tribute to Ernest L. Mazzaferri, MD and the lasting impact that he had on thyroid cancer care ten years after his death

被引：0
作者：
David S. Cooper
Matthew D. Ringel
机构：
[1] The Johns Hopkins University School of Medicine,Division of Endocrinology, Diabetes, and Metabolism
[2] The Ohio State University Wexner Medical Center & Comprehensive Cancer Center,Department of Molecular Medicine and Therapeutics
来源：
Endocrine | 2023年 / 80卷
关键词：
Thyroid cancer; Thyroid nodules; Thyroid neoplasia;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
This viewpoint highlights the contributions of Dr. Ernest Mazzaferri, a prominent figure in the field of thyroid cancer care, who made significant contributions to the diagnosis and treatment of this disease. Dr. Mazzaferri’s first paper on thyroid cancer, published in 1977, established fundamental principles that remain fundamental to differentiated thyroid cancer management. He was an advocate of total thyroidectomy and of postoperative radioiodine therapy and contributed to improving thyroid fine needle aspiration techniques. Dr. Mazzaferri’s leadership in developing guidelines for the management of thyroid cancer and thyroid nodules has been influential and widely accepted. His groundbreaking work established a systematic and data-driven approach to the diagnosis and treatment of thyroid cancer that continues to shape the field of thyroid cancer care today. This Viewpoint reflects on his lasting impact ten years after his death.
引用
收藏
页码：500 / 502
页数：2
相关论文
共 45 条
  • [1] Mazzaferri EL(1977)Papillary thyroid carcinoma: the impact of therapy in 576 patients Medicine 56 171-196
  • [2] Young RL(1994)Long-term impact of initial surgical and medical therapy on papillary and follicular thyroid cancer Am. J. Med 97 418-428
  • [3] Oertel JE(1992)The results of various modalities of treatment of well differentiated thyroid carcinomas: a retrospective review of 1599 patients J. Clin. Endocrinol. Metab. 75 714-720
  • [4] Kemmerer WT(1999)A comparison of recombinant human thyrotropin and thyroid hormone withdrawal for the detection of thyroid remnant or cancer J. Clin. Endocrinol. Metab. 84 3877-3885
  • [5] Page CP(2003)A consensus report of the role of serum thyroglobulin as a monitoring method for low-risk patients with papillary thyroid carcinoma J. Clin. Endocrinol. Metab. 88 1433-1441
  • [6] Mazzaferri EL(1993)Management of a solitary thyroid nodule N. Engl. J. Med. 328 553-559
  • [7] Jhiang SM(2006)The impact of assessing specimen adequacy and number of needle passes for fine-needle aspiration biopsy of thyroid nodules Thyroid 16 55-60
  • [8] Samaan NA(2011)Fine-needle aspiration biopsy, ultrasound and BRAF(V600E) analysis - is this the best FNAB combination for most patients? Clin. Endocrinol. 75 740-742
  • [9] Schultz PN(2006)Increasing incidence of thyroid cancer in the United States, 1973–2002 JAMA 295 2164-2167
  • [10] Hickey RC(2006)Managing small thyroid cancers JAMA 295 2179-2182
12345